AbbVie acquires Apogee for $10.9B (September 2026)
AbbVie completed the acquisition of Apogee in September 2026 for $10.9B.
Source: https://news.abbvie.com/2026-09-03-AbbVie-Completes-Acquisition-of-Apogee-Therapeutics
AbbVie completed the acquisition of Apogee in September 2026 for $10.9B.
Source: https://news.abbvie.com/2026-09-03-AbbVie-Completes-Acquisition-of-Apogee-Therapeutics